Wenelia Baghoomian
YOU?
Author Swipe
View article: A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition
A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition Open
View article: The skinny on skin: The role of skin‐aware professionals in skin cancer surveillance
The skinny on skin: The role of skin‐aware professionals in skin cancer surveillance Open
Background Licensed nonmedical, skin‐aware professionals (e.g., hairdressers, massage therapists, etc.) have the potential to identify skin cancer, but baseline knowledge may not be sufficient to accomplish this goal. Following educational…
View article: Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10
Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10 Open
PHACE syndrome is associated with long-term, mild to severe morbidities including IH residua, headaches, learning differences, and progressive arteriopathy. Primary and specialty follow-up care is critical for PHACE patients into adulthood.
View article: A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative
A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative Open
Background Pyoderma gangrenosum (PG) is a rare ulcerative skin condition with no current standardized outcomes or outcome measures. With a rich investigational therapeutic pipeline, standardization of outcomes and improvement of data quali…
View article: Patient and Caregiver Motivators and Barriers to Eczema Clinical Trial Participation: Analysis of Survey Data
Patient and Caregiver Motivators and Barriers to Eczema Clinical Trial Participation: Analysis of Survey Data Open
Background Eczema clinical trials (CTs) are increasing in number, yet participation across the eczema community is low. Little is known about patient characteristics and views on motivators and barriers to CT participation (CTP). Objective…
View article: Demographic differences in self-reported barriers and facilitators to eczema clinical trial participation among adult patients and caregivers of pediatric patients.
Demographic differences in self-reported barriers and facilitators to eczema clinical trial participation among adult patients and caregivers of pediatric patients. Open
View article: The Eczema Area and Severity Index—A Practical Guide
The Eczema Area and Severity Index—A Practical Guide Open
Atopic dermatitis is a chronic inflammatory skin condition that affects approximately 18 million people in the United States. Assessing the extent and severity of atopic dermatitis is critical for determining baseline disease burden and tr…
View article: A Therapeutic Renaissance - Emerging Treatments for Atopic Dermatitis
A Therapeutic Renaissance - Emerging Treatments for Atopic Dermatitis Open
Atopic dermatitis (AD) is a chronic, inflammatory cutaneous disease that is characterized by complex immune dysregulation and skin barrier dysfunction with a wide variety of clinical phenotypes. Until recently, conventional therapeutic mod…